- Arcutis buys UK’s Ducentis for up to $400M, as charity Lifearc celebrates first exit from venture arm BioWorld Online
- Arcutis Biotherapeutics agrees to acquire LifeArc portfolio company Ducentis BioTherapeut Seeking Alpha
- VC firm LifeArc sells first portfolio company as dermatitis-focused Ducentis bought by Arcutis for $30M FierceBiotech
- View Full coverage on Google News
The wire
More investor news
From the Spotify Mafia to the Lovable Mafia: inside Stockholm’s founder network – TechCrunch Venture
UK fund managers battling to run £1bn Scale-up Fund, reports say – Sifted
Einride founders launch venture firm, targeting €450M European deep tech investments – Tech.eu
Should tech events ban Meta’s smart glasses? – Sifted
What’s driving Scottish deeptech?: ‘There’s a huge change happening’ – Sifted
Certain Energy raises £10M Series A for long-duration battery storage – Tech.eu